Raffoux, E., Cras, A., Recher, C., Boëlle, P., de Labarthe, A., Turlure, P., . . . Dombret, H. (2010). Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome. Impact Journals LLC.
Chicago ZitierstilRaffoux, Emmanuel, et al. Phase 2 Clinical Trial of 5-azacitidine, Valproic Acid, and All-trans Retinoic Acid in Patients With High-risk Acute Myeloid Leukemia or Myelodysplastic Syndrome. Impact Journals LLC, 2010.
MLA ZitierstilRaffoux, Emmanuel, et al. Phase 2 Clinical Trial of 5-azacitidine, Valproic Acid, and All-trans Retinoic Acid in Patients With High-risk Acute Myeloid Leukemia or Myelodysplastic Syndrome. Impact Journals LLC, 2010.